Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immune Cells as Mediators Between Gut Microbiota and Multiple Sclerosis: Insights From Mendelian Randomization.
Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.
Disability and race in MS: Does socioeconomic disadvantage play a role?
Effectiveness of non-pharmacological interventions for fatigue in adults with long-term conditions: a synopsis of the EIFFEL mixed-methods evidence synthesis.
The EBNA-1 Conundrum: Does Epstein-Barr Virus Invoke Autoimmune Pathology in a Population Subset by Poorly Purine-Loading Its Major Latency-Maintaining Transcript?
Application and Future Perspectives of Extracellular Vesicle-Loaded Scaffold in Spinal Cord Injury.
When the Heart Strikes the Spine: Spinal Cord Infarction Mimicking Longitudinally Extensive Transverse Myelitis (LETM) in Infective Endocarditis.
Genetic spectrum and clinical features of PMP22 point mutations in Japanese Charcot-Marie-Tooth disease.
Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study.
Triple-crush mechanism in multiple sclerosis-associated trigeminal neuralgia.
Reply to: A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome: Regarding: MOGAD is the Most Common Cause of Isolated Optic Neuritis in Children.
Effects of transcranial direct current stimulation in multiple sclerosis: Recent findings of clinical studies and animal models.
Socioeconomic status in Behçet's syndrome.
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.
A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome.
From tumors to neurons: mass spectrometry imaging in spatial lipidomics.
Miller-Fisher Syndrome Presenting With Severe Headache and Transient Loss of Consciousness: A Case Report From Yemen.
Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways.
Early injury-induced responses in the transected adult human sural nerve.
Anti-nuclear antibodies in patients with suspicion of neuromyelitis optica spectrum disorder: Frequency and significance.
From cellular heterogeneity to precision medicine: single-cell multi-omics in CNS disease research.
Brain age gap in multiple sclerosis: associated with disability but independent of serum biomarkers.
Neighborhood disadvantage and brain myelination: Insights from infancy to childhood.
RETRACTION: Framework to Segment and Evaluate Multiple Sclerosis Lesion in MRI Slices Using VGG-UNet.
RETRACTION: Automatic Intelligent System Using Medical of Things for Multiple Sclerosis Detection.
Pages
« first
‹ previous
…
1017
1018
1019
1020
1021
1022
1023
1024
1025
next ›
last »